About Zycos
Zycos is a Technology company based in Minneapolis (United States) founded in 1999 by Mary Lynne Hedley, and was acquired by MGI Pharma in September 2004. Limited information available. Its chief executive, as recorded, is Mary Lynne Hedley. Its focus areas include Business Services, AI Services and Horizontal. Its competitors include EXL, Quantiphi and Orioninc; 2 of its 3 listed competitors have raised funding.
Company details
Zycos was founded in 1999 and is headquartered in Minneapolis, United States. Operations are centered in the biopharmaceutical industry, where vaccines and immunotherapeutics for infectious diseases are developed. A proprietary ZYCOS technology platform is employed to advance these products through research and development stages. The company is led by Co-Founder and CEO Mary Lynne Hedley, with activities focused on therapeutic innovations in immunology.
- Headquarters Minneapolis, United States
- Founders Mary Lynne Hedley
- Stage Acquired
- SectorsTechnology
- Website zycos.com
- Acquired by MGI Pharma (Sep 2004)
- Investors
- Acquired byMGI Pharma
(Sep 2004)
Investors in Zycos
Zycos has secured backing from 1 investor. Prominent investors backing the company include MGI Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Oncology and acute care pharmaceuticals are developed and commercialized. | 1979 | mgipharma.com | Woodcliff Lake, United States |
Investor details for Zycos
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Zycos
1 people are tracked at Zycos (1 in leadership).
| Name | Role | Group |
|---|---|---|
Mary Lynne Hedley | Co-Founder & CEO | Leadership |
Complete people profiles for Zycos
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Zycos
2 dated milestones of Zycos across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Zycos is founded.
- Exit Acquired by MGI Pharma.
Competitors of Zycos
Zycos has 3 listed competitors in our database, 2 of them funded. They include EXL, Quantiphi and Orioninc.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| exlservice.com | 1999 | New York, United States | $10M | 21,544 | Analytics and digital solutions for healthcare and banking are provided. | |
| quantiphi.com | 2013 | Marlborough, United States | $23.5M | 2,670 | Provider of AI and machine learning services | |
| orioninc.com | 1993 | Monmouth Junction, United States | 832 | Provider of AI, data analytics, application development and IT security services |
Detailed competitors of Zycos
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in AI Core Platforms & Infrastructure
3 companies that operate in the same segment as Zycos (AI Core Platforms & Infrastructure) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Platform that provides data analysis and management solutions | 2003 | Denver, Colorado, United States | USD 2.46 B | USD 2.87 B | 5,915 | |
OpenAI is engaged in developing advanced artificial intelligence technologies. | 2015 | San Francisco, California, United States | USD 180.07 B | 11,115 | ||
AI models and chatbots are offered for industry applications. | 2021 | San Francisco, California, United States | USD 132.31 B | 6,146 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Zycos
Zycos was founded in 1999.
Zycos is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Mary Lynne Hedley is the CEO of Zycos, as recorded in our data. They have also founded this company.
Zycos was founded in 1999 and is headquartered in Minneapolis, United States. Operations are centered in the biopharmaceutical industry, where vaccines and immunotherapeutics for infectious diseases are developed. A proprietary ZYCOS technology platform is employed to advance these products through research and development stages. The company is led by Co-Founder and CEO Mary Lynne Hedley, with activities focused on therapeutic innovations in immunology.
Zycos has 1 investor. Key investors include MGI Pharma.
Yes. Zycos was acquired by MGI Pharma in September 2004.